As research on GLP-1s continues to evolve, focusing on whole-body wellnessthrough nutrient repletion , stable blood sugar, and reduced inflammation remains one of the most effective ways to prepare for a healthy pregnancy
Plaintiffs in this MDL allege that GLP-1 drugs increased the risk of NAION and that manufacturers failed to adequately warn patients and health care providers about this potential danger
Losing muscle during weight loss can lower your resting metabolic rate, making it harder to maintain results long-term and increasing the risk of weight regain
For patients considering weight management options, understanding the pharmacological rationale, potential synergies, and safety profile of combination approaches is essential for informed conversations with healthcare providers
Take once a day, recommended after meals
The accelerated approval for Eisai and Biogens Leqembi (lecanemab) was converted to a full approval based on results from the confirmatory Clarity-AD trial, which the FDA said in its statement verified the drugs benefit
